The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease

Neurology

Volumn 41, Issue 4, 1991, Pages 479-486

  Mirra, S S ^a   Heyman, A ^b   McKeel, D ^c   Sumi, S M ^d   Crain, B J ^b   Brownlee, L M ^a   Vogel, F S ^d   Hughes, J P ^d   van Belle, G ^d   Berg, L ^c   Ball, Melvyn J ^e   Bierer, Linda M ^f   Claasen, Diana ^g   Hansen, Law Rence ^h   Hart, Michael ⁱ   Hedreen, John ^j   Baltimore, B ^k   Hen Derson, Victor ^k   Hyman, Bradley T ^l   Joachim, Catharine ^l   Mark Esbery, William ^m   Mar Tinez, A Julio ^g   McKee, Ann ^l   Miller, Carol ^k   Moossy, John ^g   Nochlin, David ^d   Perl, Daniel ⁿ   Petito, Carol ^o   Rao, Gutti R ^g   Schelper, Robert L ⁱ   Slager, Ursula ^k   Terry, Robert D ^h   more..

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF IOWA   (United States)

^j JOHNS HOPKINS HOSPITAL   (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l HARVARD UNIVERSITY   (United States)

^m UNIVERSITY OF KENTUCKY   (United States)

ⁿ MOUNT SINAI MEDICAL CENTER   (United States)

^o WEILL CORNELL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AMYLOID; BRAIN; CADAVER; COGNITION DISORDERS; HUMAN; REFERENCE VALUES; REGISTRIES; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025908356     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.41.4.479     Document Type: Article

References (35)

1. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989;39:1159-1165.
2. Mirra SS, Vogel FS, Hughes JP, Brownlee LM, Heyman A. The CERAD protocol for the neuropathologic assessment of Alzheimer’s disease and related disorders [Abstract]. Neurology 1988;38(suppl 1):413.
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939-944.
4. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen S-HC. Alzheimer’s disease: a double-labeling immunohistochemical study of senile plaques. Am J Pathol 1988;132:86-101.
5. Wisniewski HM, Bancher C, Barcikowska M, Wen GY, Currie J. Spectrum of morphological appearance of amyloid deposits in Alzheimer’s disease. Acta Neuropathol (Berl) 1989;78:337-347.
6. Ishii T, Kamentani F, Haga S, Sato M. The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer’s disease. Neuropathol Appl Neurobiol 1989;15:135-147.
7. Wisniewski HM, Wen GY, Kim KS. Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol (Berl) 1989;78:22-27.
8. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Ihara Y. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol (Berl) 1988;76:541-549.
9. Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya H. Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol (Berl) 1988;77:113-119.
10. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer’s disease. Am J Pathol 1989;135:309-319.
11. Mirra SS, McKeel DW, Crain BJ, Hughes JP, van Belle G, Heyman A. Participating neuropathologists. Quality assurance in the neuropathology assessment of Alzheimer’s disease: a multicenter study of the Consortium to Establish a Registry for Alzheimer’s disease [Abstract]. J Neuropathol Exp Neurol 1990;49:336.
12. McCullagh P, Nelder JA. Generalized linear models. London: Chapman and Hall, 1984.
13. Khachaturian ZS. Diagnosis of Alzheimer’s disease. Arch Neurol 1985;42:1097-1105.
14. Wisniewski HM, Rabe A, Zigman W, Silverman W. Editorial: neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 1989;48:606-609.
15. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 1988;38:359-364.
16. Ball MJ. The pathological diagnosis of Alzheimer’s disease: present neuropathological standards and future challenges. In: Hovaguimian T, ed. Alzheimer’s disease: international prospec- tives on diagnosis. Bern, Switzerland: Hans Huber Verlag, 1987.
17. Tomlinson BE. The neuropathology of Alzheimer’s disease—issues in need of resolution (second Dorothy S. Russell memorial lecture). Neuropathol Appl Neurobiol 1989;15:491-512.
18. Mayeux R, Stern Y, Spanton S. Hetrogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985;35:453-461.
19. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985;35:1544-1550.
20. Leverenz J, Sumi SM. Parkinson’s disease in patients with Alzheimer’s disease. Arch Neurol 1986;43:662-664.
21. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson’s disease in Alzheimer’s disease patients. Neurology 1987;37:754-760.
22. Ditter SM, Brownlee LM, Mirra SS. Clinical-pathologic correlates of Parkinson’s disease features in Alzheimer’s disease [Abstract]. Neurology 1988;38:(suppl 1):231.
23. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical find pathological aspects of parkinsonism in Alzheimer’s disease: a role for extranigral factors? Arch Neurol 1989;46:651-657.
24. Hansen LA, Masliah E, Terry RD, Mirra SS. A neuropathologic subset of Alzheimer’s disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (Berl) 1989;78:194-201.
25. Hansen LA, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer’s disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
26. Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Winblad B. Histo- pathological criteria for progressive dementia disorders: clinical- pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 1987;74:209-225.
27. Wade JPH, Mirsen TR, Hachinski VC, Fisman M, Lau C, Mer- skey H. The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987;44:24-29.
28. O’Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988;45:797-798.
29. Brust JCM. Vascular dementia is overdiagnosed. Arch Neurol 1988;45:799-801.
30. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-1044.
31. Joachim CL, Morris JH, Selkoe DJ, Clinically diagnosed Alzheimer’s disease: autopsy results in 150 cases. Ann Neurol 1988;24:50-56.
32. Mann DMA, Esiri MM. The site of the earliest lesions of Alzheimer’s disease. N Engl J Med 1988;318:89-90.
33. Motte J, Williams RS. Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain. Acta Neuropathol (Berl) 1989;77:535-546.
34. Mann DMA, Brown A, Prinja D, et al. An analysis of the morphology of senile plaques in Down’s syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropathol Appl Neurobiol 1989;15:317-329.
35. Berg L, Miller JP, Storandt M, et al. Mild senile dementia of the Alzheimer type. 2. Longitudinal assessment. Ann Neurol 1988;23:477-484.